Study on the therapeutic effect, cognition and mechanism of moxibustion on adolescent depression

Status

Recruiting

Phases

Early Phase 1

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2400087679

Enrollment

Unknown

Registered

2024-08-01

Start date

2024-08-01

Completion date

Unknown

Last updated

2024-08-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Depression

Interventions

group 1:Moxibustion

group 2:Moxibustion + Drugs

group 3:Drugs

Eligibility

Sex/Gender

All

Age

12 Years to 18 Years

Inclusion criteria

Inclusion criteria: (1) aged 12-18 years, (2) met the US DSM-5 diagnostic criteria for depression with a Hamilton Depression Scale (HAMD 17th edition) score of =7 and a Self-Depression Scale (SDS) score of =53, (3) met the symptomatic criteria for at least 2 weeks, and (4) voluntarily enrolled in this study and signed an informed consent form.

Exclusion criteria

Exclusion criteria: (1) any other Axis I psychiatric disorders; (2) previous manic episodes or meeting criteria for mania; (3) somatic disorders (e.g., cardiovascular disease, endocrine system disorders, systemic infections, etc.) and immune system disorders; (4) abuse or dependence on psychoactive substances; (5) use of antidepressant medications for moxibustion group treatment or psychotherapy or physical therapy; (6) moxibustion sites that have an open wound, abscess, or a high fever and other inappropriate moxibustion; (7) pregnant or lactating women.

Design outcomes

Primary

Measure	Time frame
BDNF;cortisol;Inflammatory factor ;	—

Countries

China

Contacts

Public ContactXiuli Song

Yantai Affiliated Hospital of Binzhou Medical University

sxl317@126.com+86 186 6389 1757

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026